Glassman Wealth Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Glassman Wealth Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-306	Closed	-$22K	–	1728
2020 Q4	$22K	Buy	+306	New	+$22.7K	0.01%	510
2020 Q2	–	Sell	-36	Closed	-$1K	–	1668
2020 Q1	$1K	Buy	36 +10	+38%	+$338	﹤0.01%	1073
2019 Q4	$1K	Buy	26 +4	+18%	+$123	﹤0.01%	1129
2019 Q3	$1K	Hold	22	–	–	﹤0.01%	1002
2019 Q2	$1K	Hold	22	–	–	﹤0.01%	1022
2019 Q1	$1K	Hold	22	–	–	﹤0.01%	990
2018 Q4	$0	Hold	22	–	–	﹤0.01%	1078
2018 Q3	$0	Hold	22	–	–	﹤0.01%	1029
2018 Q2	$0	Hold	22	–	–	﹤0.01%	1029
2018 Q1	$0	Buy	+22	New	+$325	﹤0.01%	1013

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Glassman Wealth Services's HZNP Position: Q1 2021 in Review

Glassman Wealth Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 306 shares — an estimated $22K sold.

Glassman Wealth Services first reported a position in HZNP in Q1 2018 and held it in 10 quarters. The position peaked at $22K in Q4 2020. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

Glassman Wealth Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Glassman Wealth Services sold 306 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $22K.
Glassman Wealth Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 10 quarters.
Glassman Wealth Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $22K in Q4 2020.
516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Glassman Wealth Services's 13F filing for Q1 2021, filed 5 May 2021.